esomeprazole 40 mg

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

GERD

Conditions

GERD

Trial Timeline

Jul 1, 2008 → Mar 1, 2011

About esomeprazole 40 mg

esomeprazole 40 mg is a pre-clinical stage product being developed by Johnson & Johnson for GERD. The current trial status is completed. This product is registered under clinical trial identifier NCT01079884. Target conditions include GERD.

What happened to similar drugs?

12 of 20 similar drugs in GERD were approved

Approved (12) Terminated (0) Active (8)
OMEZ 40 + OMEZ 80Dr. Reddy's LaboratoriesApproved
omeprazole+domperidone SR + omeprazoleDr. Reddy's LaboratoriesApproved
EsomeprazoleAstraZenecaApproved
EsomeprazoleAstraZenecaApproved
EsomeprazoleAstraZenecaApproved
Esomeprazole (Nexium)AstraZenecaApproved

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01079884Pre-clinicalCompleted

Competing Products

20 competing products in GERD

See all competitors
ProductCompanyStageHype Score
OMEZ 40 + OMEZ 80Dr. Reddy's LaboratoriesApproved
40
omeprazole+domperidone SR + omeprazoleDr. Reddy's LaboratoriesApproved
36
Rabeprazole ER + RanitidineEisaiPhase 3
40
Rabeprazole sodiumEisaiPhase 1
29
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
40
rabeprazole sodium + PlaceboEisaiPhase 3
40
Rabeprazole ER + RanitidineEisaiPhase 3
40
Rabeprazole sodium 5 mg + Rabeprazole sodium 10 mgEisaiPhase 1
29
rabeprazole + rabeprazoleEisaiPhase 3
40
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
40
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
40
ONO-8539Ono PharmaceuticalPhase 1
29
esomeprazole (Nexium®) + Xolaam®AstraZenecaApproved
43
esomeprazoleAstraZenecaPre-clinical
26
EsomeprazoleAstraZenecaApproved
43
EsomeprazoleAstraZenecaApproved
43
esomeprazole magnesiumAstraZenecaPhase 1
29
EsomeprazoleAstraZenecaApproved
43
EsomeprazoleAstraZenecaPhase 3
40
Esomeprazole (Nexium)AstraZenecaApproved
43